Akebia Therapeutics Inc (NASDAQ: AKBA) kicked off on Tuesday, up 0.26% from the previous trading day, before settling in for the closing price of $3.84.
Akebia Therapeutics Inc (NASDAQ: AKBA) on Friday, plunged -1.26% from the previous trading day, before settling in for the closing price of $3.98. Within the
A new trading day began on Monday, with Akebia Therapeutics Inc (NASDAQ: AKBA) stock price up 0.28% from the previous day of trading, before settling
As on Wednesday, Akebia Therapeutics Inc (NASDAQ: AKBA) got off with the flyer as it spiked 1.68% to $3.63, before settling in for the price
Akebia Therapeutics Inc (NASDAQ: AKBA) on Monday, plunged -2.41% from the previous trading day, before settling in for the closing price of $3.74. Within the
A new trading day began on Friday, with Akebia Therapeutics Inc (NASDAQ: AKBA) stock price down -2.47% from the previous day of trading, before settling
Akebia Therapeutics Inc (NASDAQ: AKBA) kicked off on Friday, up 7.59% from the previous trading day, before settling in for the closing price of $3.69.
Witnessing the stock’s movement on the chart, on Wednesday, Akebia Therapeutics Inc (NASDAQ: AKBA) set off with pace as it heaved 6.43% to $3.64, before
On Friday, Akebia Therapeutics Inc (NASDAQ: AKBA) was 0.66% up from the session before settling in for the closing price of $3.01. A 52-week range
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.